Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 69

1.

Central nervous system tumor registration in the Swedish Cancer Register and Inpatient Register between 1990 and 2014.

Tettamanti G, Ljung R, Ahlbom A, Talbäck M, Lannering B, Mathiesen T, Segerlind JP, Feychting M.

Clin Epidemiol. 2019 Jan 4;11:81-92. doi: 10.2147/CLEP.S177683. eCollection 2019.

2.

Prognostic effect of whole chromosomal aberration signatures in standard-risk, non-WNT/non-SHH medulloblastoma: a retrospective, molecular analysis of the HIT-SIOP PNET 4 trial.

Goschzik T, Schwalbe EC, Hicks D, Smith A, Zur Muehlen A, Figarella-Branger D, Doz F, Rutkowski S, Lannering B, Pietsch T, Clifford SC.

Lancet Oncol. 2018 Dec;19(12):1602-1616. doi: 10.1016/S1470-2045(18)30532-1. Epub 2018 Nov 1.

3.

Parental age and risk of genetic syndromes predisposing to nervous system tumors: nested case-control study.

Adel Fahmideh M, Tettamanti G, Lavebratt C, Talbäck M, Mathiesen T, Lannering B, Johnson KJ, Feychting M.

Clin Epidemiol. 2018 Jun 20;10:729-738. doi: 10.2147/CLEP.S159183. eCollection 2018.

4.

Spectrum and prevalence of genetic predisposition in medulloblastoma: a retrospective genetic study and prospective validation in a clinical trial cohort.

Waszak SM, Northcott PA, Buchhalter I, Robinson GW, Sutter C, Groebner S, Grund KB, Brugières L, Jones DTW, Pajtler KW, Morrissy AS, Kool M, Sturm D, Chavez L, Ernst A, Brabetz S, Hain M, Zichner T, Segura-Wang M, Weischenfeldt J, Rausch T, Mardin BR, Zhou X, Baciu C, Lawerenz C, Chan JA, Varlet P, Guerrini-Rousseau L, Fults DW, Grajkowska W, Hauser P, Jabado N, Ra YS, Zitterbart K, Shringarpure SS, De La Vega FM, Bustamante CD, Ng HK, Perry A, MacDonald TJ, Hernáiz Driever P, Bendel AE, Bowers DC, McCowage G, Chintagumpala MM, Cohn R, Hassall T, Fleischhack G, Eggen T, Wesenberg F, Feychting M, Lannering B, Schüz J, Johansen C, Andersen TV, Röösli M, Kuehni CE, Grotzer M, Kjaerheim K, Monoranu CM, Archer TC, Duke E, Pomeroy SL, Shelagh R, Frank S, Sumerauer D, Scheurlen W, Ryzhova MV, Milde T, Kratz CP, Samuel D, Zhang J, Solomon DA, Marra M, Eils R, Bartram CR, von Hoff K, Rutkowski S, Ramaswamy V, Gilbertson RJ, Korshunov A, Taylor MD, Lichter P, Malkin D, Gajjar A, Korbel JO, Pfister SM.

Lancet Oncol. 2018 Jun;19(6):785-798. doi: 10.1016/S1470-2045(18)30242-0. Epub 2018 May 9.

5.

Information needs of survivors and families after childhood CNS tumor treatment: a population-based study.

Hovén E, Lannering B, Gustafsson G, Boman KK.

Acta Oncol. 2018 May;57(5):649-657. doi: 10.1080/0284186X.2017.1406136. Epub 2017 Dec 1.

PMID:
29191069
6.

Minimal methylation classifier (MIMIC): A novel method for derivation and rapid diagnostic detection of disease-associated DNA methylation signatures.

Schwalbe EC, Hicks D, Rafiee G, Bashton M, Gohlke H, Enshaei A, Potluri S, Matthiesen J, Mather M, Taleongpong P, Chaston R, Silmon A, Curtis A, Lindsey JC, Crosier S, Smith AJ, Goschzik T, Doz F, Rutkowski S, Lannering B, Pietsch T, Bailey S, Williamson D, Clifford SC.

Sci Rep. 2017 Oct 18;7(1):13421. doi: 10.1038/s41598-017-13644-1.

7.

Correction: A new GTF2I-BRAF fusion mediating MAPK pathway activation in pilocytic astrocytoma.

Tomić TT, Olausson J, Wilzén A, Sabel M, Truvé K, Sjögren H, Dósa S, Tisell M, Lannering B, Enlund F, Martinsson T, Åman P, Abel F.

PLoS One. 2017 Sep 7;12(9):e0184715. doi: 10.1371/journal.pone.0184715. eCollection 2017.

8.

Hypothermia after cranial irradiation protects neural progenitor cells in the subventricular zone but not in the hippocampus.

Sabel M, Kalm M, Björk-Eriksson T, Lannering B, Blomgren K.

Int J Radiat Biol. 2017 Aug;93(8):771-783. doi: 10.1080/09553002.2017.1321810. Epub 2017 May 24.

PMID:
28452566
9.

A new GTF2I-BRAF fusion mediating MAPK pathway activation in pilocytic astrocytoma.

Tomić TT, Olausson J, Wilzén A, Sabel M, Truvé K, Sjögren H, Dósa S, Tisell M, Lannering B, Enlund F, Martinsson T, Åman P, Abel F.

PLoS One. 2017 Apr 27;12(4):e0175638. doi: 10.1371/journal.pone.0175638. eCollection 2017. Erratum in: PLoS One. 2017 Sep 7;12 (9):e0184715.

10.

Stem cell cultures derived from pediatric brain tumors accurately model the originating tumors.

Wenger A, Larsson S, Danielsson A, Elbæk KJ, Kettunen P, Tisell M, Sabel M, Lannering B, Nordborg C, Schepke E, Carén H.

Oncotarget. 2017 Mar 21;8(12):18626-18639. doi: 10.18632/oncotarget.14826.

11.

Prenatal and Postnatal Medical Conditions and the Risk of Brain Tumors in Children and Adolescents: An International Multicenter Case-Control Study.

Tettamanti G, Shu X, Adel Fahmideh M, Schüz J, Röösli M, Tynes T, Grotzer M, Johansen C, Klaeboe L, Kuehni CE, Lannering B, Schmidt LS, Vienneau D, Feychting M.

Cancer Epidemiol Biomarkers Prev. 2017 Jan;26(1):110-115. doi: 10.1158/1055-9965.EPI-16-0451. Epub 2016 Sep 13.

12.

Common genetic variations in cell cycle and DNA repair pathways associated with pediatric brain tumor susceptibility.

Adel Fahmideh M, Lavebratt C, Schüz J, Röösli M, Tynes T, Grotzer MA, Johansen C, Kuehni CE, Lannering B, Prochazka M, Schmidt LS, Feychting M.

Oncotarget. 2016 Sep 27;7(39):63640-63650. doi: 10.18632/oncotarget.11575.

13.

Relapse patterns and outcome after relapse in standard risk medulloblastoma: a report from the HIT-SIOP-PNET4 study.

Sabel M, Fleischhack G, Tippelt S, Gustafsson G, Doz F, Kortmann R, Massimino M, Navajas A, von Hoff K, Rutkowski S, Warmuth-Metz M, Clifford SC, Pietsch T, Pizer B, Lannering B; SIOP-E Brain Tumour Group.

J Neurooncol. 2016 Sep;129(3):515-524. doi: 10.1007/s11060-016-2202-1. Epub 2016 Jul 16.

14.

Active video gaming improves body coordination in survivors of childhood brain tumours.

Sabel M, Sjölund A, Broeren J, Arvidsson D, Saury JM, Blomgren K, Lannering B, Emanuelson I.

Disabil Rehabil. 2016 Oct;38(21):2073-84. doi: 10.3109/09638288.2015.1116619. Epub 2016 Jan 5.

PMID:
26728453
15.

A multinational case-control study on childhood brain tumours, anthropogenic factors, birth characteristics and prenatal exposures: A validation of interview data.

Vienneau D, Infanger D, Feychting M, Schüz J, Schmidt LS, Poulsen AH, Tettamanti G, Klæboe L, Kuehni CE, Tynes T, Von der Weid N, Lannering B, Röösli M.

Cancer Epidemiol. 2016 Feb;40:52-9. doi: 10.1016/j.canep.2015.11.006. Epub 2015 Nov 25.

PMID:
26625087
16.

Biomarker-driven stratification of disease-risk in non-metastatic medulloblastoma: Results from the multi-center HIT-SIOP-PNET4 clinical trial.

Clifford SC, Lannering B, Schwalbe EC, Hicks D, O'Toole K, Nicholson SL, Goschzik T, Zur Mühlen A, Figarella-Branger D, Doz F, Rutkowski S, Gustafsson G, Pietsch T; SIOP-Europe PNET Group.

Oncotarget. 2015 Nov 17;6(36):38827-39. doi: 10.18632/oncotarget.5149.

17.

Neuropsychological Outcome of Children Treated for Standard Risk Medulloblastoma in the PNET4 European Randomized Controlled Trial of Hyperfractionated Versus Standard Radiation Therapy and Maintenance Chemotherapy.

Câmara-Costa H, Resch A, Kieffer V, Lalande C, Poggi G, Kennedy C, Bull K, Calaminus G, Grill J, Doz F, Rutkowski S, Massimino M, Kortmann RD, Lannering B, Dellatolas G, Chevignard M; Quality of Survival Working Group of the Brain Tumour Group of SIOP-Europe.

Int J Radiat Oncol Biol Phys. 2015 Aug 1;92(5):978-985. doi: 10.1016/j.ijrobp.2015.04.023. Epub 2015 Apr 17.

PMID:
26194675
18.

MethPed: a DNA methylation classifier tool for the identification of pediatric brain tumor subtypes.

Danielsson A, Nemes S, Tisell M, Lannering B, Nordborg C, Sabel M, Carén H.

Clin Epigenetics. 2015 Jul 9;7:62. doi: 10.1186/s13148-015-0103-3. eCollection 2015.

19.

CCDC26, CDKN2BAS, RTEL1 and TERT Polymorphisms in pediatric brain tumor susceptibility.

Adel Fahmideh M, Lavebratt C, Schüz J, Röösli M, Tynes T, Grotzer MA, Johansen C, Kuehni CE, Lannering B, Prochazka M, Schmidt LS, Feychting M.

Carcinogenesis. 2015 Aug;36(8):876-82. doi: 10.1093/carcin/bgv074. Epub 2015 May 25.

20.

Altered self-perception in adult survivors treated for a CNS tumor in childhood or adolescence: population-based outcomes compared with the general population.

Hörnquist L, Rickardsson J, Lannering B, Gustafsson G, Boman KK.

Neuro Oncol. 2015 May;17(5):733-40. doi: 10.1093/neuonc/nou289. Epub 2014 Oct 20.

Supplemental Content

Loading ...
Support Center